Gilead Sciences Closes Durham, North Carolina R&D Office
06/24/2010
"This comes after a lengthy review," Flood said. "We will be consolidating our R&D activities in our Foster City, [California] headquarters."
The Durham closure leaves Gilead with no presence in North Carolina.
Gilead is a bioscience company that conducts anti-viral research and development. The Durham office conducted hepatitis B and C clinical research.
Most Read
-
-
What’s Driving Record Industrial Real Estate Demand
Q1 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2020
-
Pandemic Fuels Data Center Growth
Q1 2021
-
Trends in Office and Industrial Parks
Q4 2020
-
35th Annual Survey of Corporate Executives Commentary: Change in Site Selection Priorities and Plans Over the Short and Long Term
Q1 2021